Some rare HIV-1-infected individuals, referred to as HIV controllers (HIC), have persistently
undetectable plasma viral load in the absence of therapy. This control of HIV-1 replication …

HIV-2 is less pathogenic for humans than HIV-1 and might provide partial cross-protection
from HIV-1-induced pathology. Although both viruses replicate in the T cells of infected …

“HIV controllers”(HICs) are rare individuals in whom HIV-1 plasma viral load remains
undetectable without antiretroviral treatment. This spontaneous viral control in HICs is usually …

The persistence of the HIV reservoir in infected individuals is a major obstacle to the development
of a cure for HIV 1 , 2 , 3 . Here, using an in vitro model of HIV-infected quiescent CD4 …

Background To address the unmet medical need for an effective prophylactic vaccine
against Ebola virus we assessed the safety and immunogenicity of three different two-dose …

Human immunodeficiency virus (HIV) controllers are rare individuals who spontaneously
control HIV type 1 replication for 10 years or more in the absence of antiretroviral treatment. In …

The identification of patients with coronavirus disease 2019 and high risk of severe disease
is a challenge in routine care. We performed cell phenotypic, serum, and RNA sequencing …

Efforts aimed at restoring robust immune responses limiting human immunodeficiency virus (HIV)‐1
replication therapeutically are warranted. We report that vaccination with dendritic …

In the present study, we have investigated the functional profile of CD4 T cells from patients
with common variable immunodeficiency (CVID), including production of cytokines and …

Background We investigated safety, tolerability, and immunogenicity of the heterologous 2-dose
Ebola vaccination regimen in healthy and HIV-infected adults with different intervals …